@article{796952a9c2e1409391af3d06af68c865,
title = "First trimester diclofenac exposure and pregnancy outcome",
abstract = "To assess the safety of diclofenac during pregnancy.",
keywords = "Abnormalities, Drug-Induced, Abortion, Spontaneous, Adult, Anti-Inflammatory Agents, Non-Steroidal, Cohort Studies, Diclofenac, Female, Follow-Up Studies, Humans, Middle Aged, Pregnancy, Pregnancy Outcome, Pregnancy Trimester, First, Prospective Studies, Questionnaires, Young Adult, Abnormalities, Drug-Induced, Abortion, Spontaneous, Adult, Anti-Inflammatory Agents, Non-Steroidal, Cohort Studies, Diclofenac, Female, Follow-Up Studies, Humans, Middle Aged, Pregnancy, Pregnancy Outcome, Pregnancy Trimester, First, Prospective Studies, Questionnaires, Young Adult",
author = "M Cassina and {De Santis}, Marco and Elena Cesari and {Van Eijkeren}, M and M Berkovitch and G Eleftheriou and F Raffagnato and {Di Gianantonio}, E and M. Clementi",
year = "2010",
doi = "10.1016/j.reprotox.2010.04.010",
language = "English",
volume = "30",
pages = "401--404",
journal = "Reproductigve Toxicoloy",
issn = "0890-6238",
publisher = "Elsevier Science Limited:Oxford Fulfillment Center, PO Box 800, Kidlington Oxford OX5 1DX United Kingdom:011 44 1865 843000, 011 44 1865 843699, EMAIL: asianfo@elsevier.com, tcb@elsevier.co.UK, INTERNET: http://www.elsevier.com, http://www.elsevier.com/locate/shpsa/, Fax: 011 44 1865 843010",
}